Get the Stockscreener App
1.50
2.04%
0.03
Context Therapeutics Inc Stock (CNTX) Forecast
The Context Therapeutics Inc (CNTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.874, representing a +24.93% increase from the current price of $1.50. The highest analyst price target is $1.98, and the lowest is $1.768.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CNTX Price Target
Average 1.6496
(+9.97% Upside)
Is Context Therapeutics Inc (CNTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 31.37 | Neutral |
| STOCH(9,6) | 24.40 | Neutral |
| STOCHRSI(14) | 35.03 | Neutral |
| MACD(12,26) | -0.1713 | Sell |
| ADX(14) | 29.46 | Sell |
| William %R | -72.29 | Neutral |
| CCI(14) | -65.69 | Neutral |
Buy: 0
Sell: 2
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.602
Sell
|
1.6075
Sell
|
| MA20 |
1.8615
Sell
|
1.7616
Sell
|
| MA50 |
1.9588
Sell
|
1.936
Sell
|
| MA100 |
2.1274
Sell
|
1.9761
Sell
|
| MA200 |
1.8412
Sell
|
1.836
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CNTX could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 12 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on CNTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 31.37 indicates that CNTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 24.4 indicates that CNTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 35.03 indicates that CNTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.46 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -65.69 indicates that CNTX is still oversold but not to an extreme extent.
Long-term CNTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Context Therapeutics Inc financial reports and earnings history, Context Therapeutics Inc (CNTX) stock could reach $0.6996 by 2030, $15.66 by 2040 and $10.10 by 2050. See the projected annual prices until 2050 of the Context Therapeutics Inc stock below:
- Context Therapeutics Inc (CNTX) is expected to reach an average price of $6.5251 in 2035, with a high prediction of $6.5127 and a low estimate of $6.5083. This indicates an $335.01% rise from the last recorded price of $1.50.
- Context Therapeutics Inc (CNTX) stock is projected to chart a bullish course in 2040, with an average price target of $15.35, representing an $923.42% surge from its current level. The forecast ranges from a conservative $15.51 to a sky-high $15.66.
- Our analysts predict Context Therapeutics Inc (CNTX) to jump 1,670% by 2045, soaring from $26.73 to an average price of $26.55, potentially reaching $26.71. While $26.73 is the low estimate, the potential upside is significant.
- Context Therapeutics Inc (CNTX) stock is expected to climb by 2050, reaching an average of $9.5492, a $536.61% jump from its current level. However, a wide range of estimates exists, with high and low targets of $10.10 and $9.6542, respectively, highlighting the market's uncertainty.
Context Therapeutics Inc Stock (CNTX) Year by Year Forecast
Context Therapeutics Inc Stock (CNTX) Price Forecast for 2024
Our forecast for CNTX stock price in 2024 now indicates an average price target of $3.5528 with a high forecast of $6.829 and a low forecast of $0.2766. The average prediction reflects an increase of +136.85% from the last recorded price of $1.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $1.4084 | $1.768 | $1.98 | -6.11% |
Context Therapeutics Inc Stock (CNTX) Price Forecast for 2025
Context Therapeutics Inc Stock (CNTX) is expected to reach an average price of $1.6496 in 2025, with a high prediction of $2.0156 and a low estimate of $1.2835. This indicates an +9.97% rise from the last recorded price of $1.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.2544 | $1.2944 | $1.446 | -16.38% |
| February, 2025 | $1.3111 | $1.2835 | $1.2222 | -12.59% |
| March, 2025 | $1.2279 | $1.3836 | $1.1803 | -18.14% |
| April, 2025 | $1.2639 | $1.2955 | $1.1755 | -15.74% |
| May, 2025 | $1.8406 | $1.6131 | $1.8006 | +22.71% |
| June, 2025 | $1.6574 | $1.7074 | $1.859 | +10.49% |
| July, 2025 | $1.4334 | $1.4834 | $1.6253 | -4.44% |
| August, 2025 | $2.1002 | $1.5424 | $2.0033 | +40.01% |
| September, 2025 | $1.9534 | $1.9676 | $2.0156 | +30.23% |
| October, 2025 | $1.7153 | $1.6845 | $1.8761 | +14.35% |
| November, 2025 | $1.7699 | $1.7405 | $1.7033 | +17.99% |
| December, 2025 | $1.7308 | $1.7956 | $1.7373 | +15.39% |
Context Therapeutics Inc Stock (CNTX) Price Forecast for 2026
The predicted value for Context Therapeutics Inc (CNTX) in 2026 is set at an average of $0.9339. Estimates vary from a peak of $1.6941 to a trough of $0.1737, indicating an -37.74% surge from the present price of $1.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.7157 | $1.7348 | $1.6941 | +14.38% |
| February, 2026 | $0.9092 | $1.3492 | $1.6016 | -39.39% |
| March, 2026 | $0.506 | $0.821 | $0.8576 | -66.27% |
| April, 2026 | $0.9019 | $0.6651 | $0.8519 | -39.87% |
| May, 2026 | $0.9187 | $0.9187 | $0.7212 | -38.75% |
| June, 2026 | $0.8703 | $0.8771 | $0.8263 | -41.98% |
| July, 2026 | $0.6014 | $0.5122 | $0.7147 | -59.90% |
| August, 2026 | $0.5851 | $0.559 | $0.5709 | -60.99% |
| September, 2026 | $0.6927 | $0.6274 | $0.6358 | -53.82% |
| October, 2026 | $0.2684 | $0.321 | $0.4453 | -82.11% |
| November, 2026 | $0.3577 | $0.3401 | $0.3177 | -76.15% |
| December, 2026 | $0.1337 | $0.1737 | $0.3169 | -91.09% |
Context Therapeutics Inc Stock (CNTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Context Therapeutics Inc (CNTX) is $2.8007, with a high forecast of $5.601 and a low forecast of $0.000339. This indicates an +86.71% increase from the last price of $1.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.0255 | $0.1305 | $0.0729 | -98.30% |
| February, 2027 | $0.2128 | $0.000339 | $0.4728 | -85.82% |
| March, 2027 | $2.8384 | $0.2136 | $2.3334 | +89.23% |
| April, 2027 | $2.7819 | $3.0735 | $2.9152 | +85.46% |
| May, 2027 | $5.2555 | $3.6203 | $4.7255 | +250.37% |
| June, 2027 | $5.6674 | $5.5739 | $5.5875 | +277.83% |
| July, 2027 | $5.751 | $5.6658 | $5.601 | +283.40% |
| August, 2027 | $5.2745 | $5.6376 | $5.5994 | +251.63% |
| September, 2027 | $5.3664 | $4.8481 | $5.0013 | +257.76% |
| October, 2027 | $5.55 | $5.5648 | $5.48 | +270.00% |
| November, 2027 | $4.8335 | $4.9052 | $5.1184 | +222.24% |
| December, 2027 | $4.5655 | $4.6171 | $4.8419 | +204.36% |
Context Therapeutics Inc Stock (CNTX) Price Forecast for 2028
In 2028, Context Therapeutics Inc (CNTX) is projected to reach an average price of $4.3398, with a high projection of $4.8181 and a low estimate of $3.8615. This indicates an +189.32% rise from the last price of $1.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.5691 | $4.6339 | $4.4933 | +204.61% |
| February, 2028 | $4.3726 | $4.5126 | $4.3142 | +191.50% |
| March, 2028 | $4.8645 | $4.4193 | $4.5945 | +224.30% |
| April, 2028 | $4.8681 | $4.8881 | $4.8181 | +224.54% |
| May, 2028 | $4.47 | $4.6004 | $4.5448 | +198.00% |
| June, 2028 | $4.7136 | $4.2968 | $4.2949 | +214.24% |
| July, 2028 | $4.5971 | $4.7564 | $4.7334 | +206.47% |
| August, 2028 | $4.257 | $4.269 | $4.5489 | +183.80% |
| September, 2028 | $4.2326 | $4.2419 | $4.2046 | +182.17% |
| October, 2028 | $4.2161 | $4.2209 | $4.1669 | +181.07% |
| November, 2028 | $4.0469 | $4.0697 | $4.1346 | +169.80% |
| December, 2028 | $3.5816 | $3.8615 | $3.9871 | +138.77% |
Context Therapeutics Inc Stock (CNTX) Price Forecast for 2029
The 2029 price forecast for Context Therapeutics Inc Stock (CNTX) is $2.1838 on average, with a high prediction of $3.30 and a low estimate of $1.0677. This represents an +45.59% increase from the previous price of $1.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.9135 | $3.0335 | $3.30 | +94.24% |
| February, 2029 | $2.9271 | $2.7503 | $2.8108 | +95.14% |
| March, 2029 | $2.7706 | $2.9022 | $2.8565 | +84.71% |
| April, 2029 | $2.7542 | $2.7542 | $2.6691 | +83.61% |
| May, 2029 | $2.1961 | $2.446 | $2.6826 | +46.41% |
| June, 2029 | $2.3196 | $2.2645 | $2.2607 | +54.64% |
| July, 2029 | $2.3471 | $2.228 | $2.1848 | +56.47% |
| August, 2029 | $1.9051 | $2.0951 | $2.2216 | +27.01% |
| September, 2029 | $1.7187 | $1.7803 | $1.7336 | +14.58% |
| October, 2029 | $1.5907 | $1.6406 | $1.6955 | +6.05% |
| November, 2029 | $1.2642 | $1.3858 | $1.3374 | -15.72% |
| December, 2029 | $1.0277 | $1.0677 | $1.1825 | -31.49% |
Context Therapeutics Inc Stock (CNTX) Price Forecast for 2030
Context Therapeutics Inc Stock (CNTX) is expected to reach an average price of $5.1228 in 2030, with a high forecast of $9.466 and a low forecast of $0.7796. This signifies an +241.52% surge from the last price of $1.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.7396 | $0.7796 | $0.6996 | -50.69% |
| February, 2030 | $7.1477 | $7.235 | $6.9977 | +376.52% |
| March, 2030 | $9.0281 | $7.1353 | $7.1118 | +501.87% |
| April, 2030 | $9.4984 | $9.2556 | $9.1524 | +533.23% |
| May, 2030 | $9.4763 | $9.4987 | $9.466 | +531.75% |
| June, 2030 | $9.2766 | $9.3665 | $9.3714 | +518.44% |
| July, 2030 | $8.4745 | $8.7345 | $9.1442 | +464.97% |
| August, 2030 | $9.1748 | $8.4521 | $8.9448 | +511.66% |
| September, 2030 | $8.3251 | $8.6847 | $8.9824 | +455.01% |
| October, 2030 | $7.9631 | $8.0031 | $8.2379 | +430.87% |
| November, 2030 | $7.8534 | $7.9334 | $7.8102 | +423.56% |
| December, 2030 | $7.6037 | $7.7637 | $7.681 | +406.91% |
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):